Reduced FMR1 mRNA translation efficiency in fragile X patients with premutations

RNA

Volumn 8, Issue 12, 2002, Pages 1482-1488

  Primerano, Beatrice ^a   Tassone, Flora ^b   Hagerman, Randi J ^c   Hagerman, Paul ^b   Amaldi, Francesco ^a   Bagni, Claudia ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

FRAXA; Mental retardation; mRNA translation; Repeat expansion

Indexed keywords

CYSTEINYLGLYCYLGLYCINE; FRAGILE X MENTAL RETARDATION PROTEIN; MESSENGER RNA; TRINUCLEOTIDE; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ARTICLE; CLINICAL ARTICLE; FEMALE; FRAGILE X SYNDROME; HETEROZYGOTE; HUMAN; LYMPHOBLASTOID CELL; MALE; MENTAL DEFICIENCY; MUTATION; POLYSOME; PRIORITY JOURNAL; RNA TRANSLATION; TRINUCLEOTIDE REPEAT;

CELL LINE; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; HETEROZYGOTE; HUMANS; LYMPHOCYTES; MALE; MUTATION; NERVE TISSUE PROTEINS; PROTEIN BIOSYNTHESIS; RNA, MESSENGER; RNA-BINDING PROTEINS; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 0036918690     PISSN: 13558382     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Bagni C, Mannucci L, Dotti C, Amaldi F. 2000. Synaptic mRNAs are actively translated and translation efficiency changes by membrane depolarization. J Neurosci 20:RC76, 1-6.
2. Bardoni B, Mandel JL. 2002. Advances in understanding of fragile X pathogenesis and FMRP function, and in identification of X linked mental retardation genes. Curr Opin Genet Dev 12:284-293.
3. Darnell JC, Jensen KB, Jin P, Brown V, Warren ST, Darnell RB. 2001. Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell 107:489-499.
4. Devys D, Lutz Y, Rouyer N, Bellocq JP, Mandel JL. 1993. The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat Genet 4:335-340.
5. Dorn MB, Mazzocco MM, Hagerman RJ. 1994. Behavioral and psychiatric disorders in adult male carriers of fragile X. J Am Acad Child Adolesc Psychiatry 33:256-264.
6. Feng Y, Gutekunst CA, Eberhart DE, Yi H, Warren ST, Hersch SM. 1997. Fragile X mental retardation protein: Nucleocytoplasmic shuttling and association with somatodenddtic ribosomes. J Neurosci 17:1539-1547.
7. Feng Y, Zhang F, Lokey LK, Chastain JL, Lakkis L, Eberhart D, Warren ST. 1995. Translational suppression by tdnucleotide repeat expansion at FMR1. Science 268:731-734.
8. Franke P, Lebover M, Gansicke M, Weiffenbach O, Biancalana V, Cornillet-Lefebre P, Croquette MF, Froster U, Schwab SG, Poustka F, Hautzinger M, Maier W. 1998. Genotype-phenotype relationship in female carriers of the premutation and full mutation of FMR-1. Psychiatry Res 80:113-127.
9. Fu YH, Kuhl DP, Pizzuti A, Pieretti M, Sutcliffe JS, Richards S, Verkerk AJ, Holden JJ, Fenwick RG Jr, Warren ST, Oostra BA, Nelson DL, Caskey CT. 1991. Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox. Cell 67:1047-1058.
10. Gedeon AK, Baker E, Robinson H, Partington MW, Gross B, Manca A, Korn B, Poustka A, Yu S, Sutherland GR, Mulley JC. 1992. Fragile X syndrome without CCG amplification has an FMR1 deletion. Nat Genet 1:341-344.
11. Hagerman RJ, Staley LW, O'Conner R, Lugenbeel K, Nelson D, McLean SD, Taylor A. 1996. Learning-disabled males with a fragile X CGG expansion in the upper premutation size range. Pediatrics 97:122-126.
12. Kenneson A, Zhang F, Hagedorn CH, Warren ST. 2001. Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. Hum Mol Genet 10:1449-1454.
13. Khandjian EW, Fortin A, Thibodeau A, Tremblay S, Cote F, Devys D, Mandel JL, Rousseau F. 1995. A heterogeneous set of FMR1 proteins is widely distributed in mouse tissues and is modulated in cell culture. Hum Mol Genet 4:783-789.
14. Kozak M. 1996. Interpreting cDNA sequences: Some insights from studies on translation. Mamm Genome 7:563-574.
15. Kremer EJ, Yu S, Pritchard M, Nagaraja R, Heitz D, Lynch M, Baker E, Hyland VJ, Little RD, Wada M, Toniolo D, Vincent A, Rousseau F, Schlessinger D, Sutherland GR, Richards RI. 1991. Isolation of a human DNA sequence which spans the fragile X. Am J Hum Genet 49:656-661.
16. Loesch DZ, Hay DA, Sutherland GR, Halliday J, Judge C, Webb GC. 1987. Phenotypic variation in male-transmitted fragile X: Genetic inferences. Am J Med Genet 27:401-417.
17. Malter HE, Iber JC, Willemsen R, de Graaff E, Tarleton JC, Leisti J, Warren ST, Oostra BA. 1997. Characterization of the full fragile X syndrome mutation in fetal gametes. Nat Genet 15:165-169.
18. Meyuhas O, Yael B, Pierandrei-Amaldi P, Amaldi F. 1996. In: Krieg PA, ed. A Laboratory Guide to RNA: Isolation, Analysis and Synthesis. New York: Wiley-Liss. pp 65-81.
19. Mila M, Castellvi-Bel S, Sanchez A, Barcelo A, Badenas C, Mallolas J, Estivill X. 2000. Rare variants in the promoter of the fragile X syndrome gene (FMR1). Mol Cell Probes 14:115-119.
20. Moutou C, Vincent MC, Biancalana V, Mandel JL. 1997. Transition from premutation to full mutation in fragile X syndrome is likely to be prezygotic. Hum Mol Genet 6:971-979.
21. Oberle I, Rousseau F, Heitz D, Kretz C, Devys D, Hanauer A, Boue J, Bertheas MF, Mandel JL. 1991. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 252:1097-1102.
22. O'Donnell WT, Warren ST. 2002. A decade of molecular studies of fragile X syndrome. Annu Rev Neurosci 25:315-338.
23. Oostra BA. 2002. Functions of the fragile X protein. Trends Mol Med 8:102-103.
24. Pieretti M, Zhang FP, Fu YH, Warren ST, Oostra BA, Caskey CT, Nelson DL. 1991. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 66:817-822.
25. Reiss AL, Abrams MT, Greenlaw R, Freud L, Denckla MB. 1995. Neurodevelopmental effects of the FMR-1 full mutation in humans. Nat Med 2:159-167.
26. Riddle JE, Cheema A, Sobesky WE, Gardner SC, Taylor AK, Pennington BF, Hagerman RJ. 1998. Phenotypic involvement in females with the FMR1 gene mutation. Am Ment Retard 102:590-601.
27. Rousseau F, Heitz D, Tarleton J, MacPherson J, Malmgren H, Dahl N, Barnicoat A, Mathew C, Mornet E, Tejada I, Maddalena A, Spiegel R, Schinzel A, Marcos JAG, Schorderet DF, Schaap T, Maccioni L, Russo S, Jacobs PA, Schwartz C, Mandel JL. 1994. A multicenter study on genotype-phenotype correlations in the fragile X syndrome, using direct diagnosis with probe STB12.3: The first 2,253 cases. Am J Hum Genet 55:225-237.
28. Rousseau F, Rouillard P, Morel ML, Khandjian EW, Morgan K. 1995. Prevalence of carriers of premutation-size alleles of the FMR1 gene - and implications for the population genetics of the fragile X syndrome. Am J Hum Genet 57:1006-1018.
29. Schaffer C, Bardoni B, Mandel JL, Ehresmann C, Moine H. 2001. The fragile X mental retardation protein binds specifically to its mRNA via a purine quartet motif. EMBO J 20:4803-4813.
30. Signori E, Bagni C, Papa S, Primerano B, Rinaldi M, Amaldi F, Fazio VM. 2001. A somatic mutation in the 5′UTR of BRCA1 gene in sporadic breast cancer causes down-modulation of translation efficiency. Oncogene 20:4596-4600.
31. Smeets HJ, Smits AP, Verheij CE, Theelen JP, Willemsen R, van de Burgt I, Hoogeveen AT, Oosterwijk JC, Oostra BA. 1995. Normal phenotype in two brothers with a full FMR1 mutation. Hum Mol Genet 4:2103-2108.
32. Smits A, Smeets D, Hamel B, Dreesen J, de Haan A, van Oost B. 1994. Prediction of mental status in carriers of the fragile X mutation using CGG repeat length. Am J Med Genet 51:497-500.
33. Snow K, Doud LK, Hagerman R, Pergolizzi RG, Erster SH, Thibodeau SN. 1993. Analysis of a CGG sequence at the FMR-1 locus in fragile X families and in the general population. Am J Hum Genet 53:1217-1228.
34. Sutcliffe JS, Nelson DL, Zhang F, Pieretti M, Caskey CT, Saxe D, Warren ST. 1992. DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum Mol Genet 1:397-400.
35. Tassone F, Hagerman RJ, Chamberlain WD, Hagerman PJ. 2000a. Transcription of the FMR1 gene in individuals with fragile X syndrome. Am J Med Genet (Semin Med Genet) 97:195-203.
36. Tassone F, Hagerman RJ, Loesch DZ, Lachiewicz A, Taylor AK, Hagerman PJ. 2000b. Fragile X males with unmethylated, full mutation trinucleotide repeat expansions have elevated levels of FMR1 messenger RNA. Am J Med Genet 94:232-236.
37. Tassone F, Hagerman RJ, Taylor AK, Gane LW, Godfrey T, Hagerman PJ. 2000c. Elevated levels of FMR1 messenger RNA in carrier males: A new mechanism of involvement in the fragile X syndrome. Am J Med Genet 66:6-15.
38. Tassone F, Hagerman RJ, Taylor AK, Hagerman PJ. 2001. A majority of fragile X males with methylated, full mutation alleles have significant levels of FMR1 messenger RNA. J Med Genet 38:453-456.
39. Tassone F, Hagerman RJ, Taylor AK, Mills JB, Harris SW, Gane LW, Hagerman PJ. 2000d. Clinical involvement and protein expression in individuals with the FMR1 premutation. Am J Med Genet 91:144-152.
40. Verkerk AJ, Pieretti M, Sutcliffe JS, Fu YH, Kuhl DP, Pizzuti A, Reiner O, Richards S, Victoria MF, Zhang FP, Eussen BE, Van Ommen GJB, Blouden LAJ, Riggins GJ, Chastain JL, Kunst CB, Galjaerd H, Caskey CT, Nelson DL, Oostra BA, Warren ST. 1991. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65:905-914.
41. Weiler IJ, Irwin SA, Klintsova AY, Spencer CM, Brazelton AD, Miyashiro K, Comery TA, Patel B, Eberwine J, Greenough WT. 1997. Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proc Natl Acad Sci USA 94:5395-5400.